Objective. Kawasaki disease (KD) is the leading cause of acquired heart disease among children in developed countries. Coronary lesions in KD in humans are characterized by an increased presence of infiltrating CD31 T cells; however, the specific contributions of the different T cell subpopulations in coronary arteritis development remain unknown. Therefore, we sought to investigate the function of CD41 and CD81 T cells, Treg cells, and natural killer (NK) T cells in the pathogenesis of KD.
Objective. Kawasaki disease (KD) is the leading cause of acquired heart disease among children in developed countries. Coronary lesions in KD in humans are characterized by an increased presence of infiltrating CD31 T cells; however, the specific contributions of the different T cell subpopulations in coronary arteritis development remain unknown. Therefore, we sought to investigate the function of CD41 and CD81 T cells, Treg cells, and natural killer (NK) T cells in the pathogenesis of KD.
Methods. We addressed the function of T cell subsets in KD development by using a well-established murine model of Lactobacillus casei cell wall extract (LCWE)-induced KD vasculitis. We determined which T cell subsets were required for development of KD vasculitis by using several knockout murine strains and depleting monoclonal antibodies.
Results. LCWE-injected mice developed coronary lesions characterized by the presence of inflammatory cell infiltrates. Frequently, this chronic inflammation resulted in complete occlusion of the coronary arteries due to luminal myofibroblast proliferation (LMP) as well as the development of coronary arteritis and aortitis. We found that CD81 T cells, but not CD41 T cells, NK T cells, or Treg cells, were required for development of KD vasculitis.
Conclusion. The LCWE-induced murine model of KD vasculitis mimics many histologic features of the disease in humans, such as the presence of CD81 T cells and LMP in coronary artery lesions as well as epicardial coronary arteritis. Moreover, CD81 T cells functionally contribute to the development of KD vasculitis in this murine model. Therapeutic strategies targeting infiltrating CD81 T cells might be useful in the management of KD in humans.
Kawasaki disease (KD) is an acute systemic vasculitis of unknown etiology affecting predominantly children ages 6 months to 5 years (1) . KD represents the leading cause of acquired heart disease among children in the US and other developed countries and is associated with the development of acute and subacute coronary arteritis and myocarditis (2) (3) (4) . The etiology of KD remains unknown, although the current paradigm is that KD could be triggered by an infectious agent that elicits inflammatory responses directed at cardiovascular tissues in genetically susceptible hosts (3) . The limited understanding of the etiologic agent(s) and of the cellular and molecular immune mechanisms involved in KD pathogenesis continue to thwart the development of more efficacious treatments or cure (5, 6) . In addition, the very limited availability of KD patient tissue samples has significantly impeded our progress in understanding KD etiology and pathogenesis, making the availability of a relevant animal model extremely valuable. KD involves systemic inflammation with a distinct predilection for the coronary arteries. KD, once thought of as an acute selflimiting disease, is now being increasingly recognized to induce long-term cardiovascular complications, including vascular changes and ongoing remodeling such as luminal myofibroblast proliferation (LMP), leading to coronary artery stenosis with both cardiovascular and myocardial complications (7) (8) (9) .
The Lactobacillus casei cell wall extract (LCWE)-induced murine model of KD vasculitis closely phenocopies the important histologic features as well as the immune and pathologic features of the disease in humans (e.g., coronary arteritis, coronary stenosis, aortitis, myocarditis, aneurysms) (10) (11) (12) (13) . A single intraperitoneal (IP) injection of LCWE into wild-type (WT) mice reproducibly induces aortitis, proximal coronary arteritis, and myocarditis as well as other systemic artery abnormalities, including abdominal aorta dilatations and even aneurysms, which are histopathologic features similar to the cardiovascular pathologies observed in KD in humans (10, (12) (13) (14) (15) . This LCWE-induced KD experimental murine model reliably predicts efficacy of treatment options in children with KD (11, 16, 17) . While no animal model can fully mimic human disease, the LCWEinduced KD murine model has been widely accepted as a reliable experimental model able to provide novel insights into KD immunopathology and potential leads for the development of therapeutic interventions aiming to treat and prevent the cardiovascular complications associated with KD. The translational value of this animal model was recently shown again, when the discovery of the key role of interleukin-1 (IL-1) signaling in the model led to the initiation of 3 phase II clinical trials with the IL-1 receptor (IL-1R) antagonist anakinra or anti-IL-1b (canakinumab) in KD patients (14, 15, 18) .
Although the mechanism of KD-induced cardiovascular lesion development is unclear, strong evidence indicates that the pathology is immune mediated (19) (20) (21) (22) . Immunohistologic analysis of tissues obtained from KD patients demonstrate the presence of dendritic cells (DCs) in the coronary lesions as well as their colocalization with CD31 T cells (19) . Circulating CD41 and CD81 T cells are also increased in KD patients with coronary lesions, and CD81 T cells are the dominant cell type present in those lesions (23, 24) . Several studies have demonstrated that the acute phase of KD is also associated with decreased numbers and compromised functions of circulating CD41CD251FoxP31 Treg cells (25, 26) . Intravenous immunoglobulin (IVIG) treatment results in increased proportions and suppressive activities of Treg cells (25, 27) .
In this study, we demonstrate that the LCWEinduced murine model of KD vasculitis phenocopies many pathologic features of KD in humans, including development of epicardial coronary arteritis as well as progressive LMP and scarring/stenosis of the coronary arteries. We also observed the presence of both CD41 and CD81 T cells in LCWE-induced coronary lesions. Although the absence of either Treg cells or natural killer (NK) T cells did not impact the development of LCWE-induced KD vasculitis, CD81 T cells played a critical role in KD development since their depletion resulted in decreased KD vasculitis and lesion formation. Finally, adoptive transfer of CD81 T cells promoted the development of vasculitis in recombination-activating gene 1-deficient (RAG-1 -/-) mice, a strain of mice known to be resistant to LCWE-induced KD (13) . The present report underlines the key function of CD81 T cells in LCWE-induced KD lesions, similar to that in KD in humans, and targeting this T cell subset during KD development could potentially lead to the generation of novel therapeutics.
MATERIALS AND METHODS
Mice. C57BL/6, CD45.11, CD4
-/-(CD4 tm1Mak ), RAG-1 -/-(RAG-1 tm1Mom ), and Cd1d -/-(Cd1 tm1Gru ) mice, all on a C57BL/6 background, were purchased from The Jackson Laboratory. FoxP3 DTR transgenic mice were a kind gift from Dr. Alexander Rudensky (Sloan-Kettering Institute, New York, NY). All animals were housed under specific pathogenfree conditions at the animal center of Cedars-Sinai Medical Center, and experiments were conducted under protocols approved by the Institutional Animal Care and Use Committee.
In vivo cell depletion. The following antibodies were injected IP at 200 mg per injection: anti-CD8a (clone 2.43; BioXcell), anti-CD8b (clone 53-5.8; BioXcell), and anti-mouse CD25 (clone PC61; eBioscience), as well as rat IgG2b (clone LTF-2; BioXcell) and rat IgG1 (clone HRPN; BioXcell) isotype controls. For in vivo Treg cell depletion with diphtheria toxin (SigmaAldrich), FoxP3 DTR mice were injected IP with 50 mg/kg of diphtheria toxin every other day as previously described (28, 29) . KD vasculitis murine model and heart pathology assessment. L casei (11578; ATCC) cell wall extract was prepared as previously described (10, 12) . Five-week-old male mice were injected IP with 500 mg of either LCWE or phosphate buffered saline (PBS). At specified days after injection, mice were euthanized and their hearts were removed and embedded in OCT compound for histologic examination. Serial cryosections (7 mm) of heart tissue were stained with hematoxylin and eosin, and histopathologic scoring of coronary arteritis, aortic root vasculitis, and myocarditis was performed by a pathologist (MCF) who was blinded to the experimental set-up. Trichrome staining and assessment of KD lesions were performed as previously described (15) . Severity of heart vessel inflammation was scored as follows: 0 5 no inflammation; 1 5 rare inflammatory cells; 2 5 scattered inflammatory cells; 3 5 diffuse infiltrate of inflammatory cells; and 4 5 dense cluster of inflammatory cells. Myocardial inflammation was scored as follows: 0 5 no myocardial fibrosis; 1 5 very minimal focal subepicardial interstitial fibrosis just infiltrating beneath epicardial fat; 2 5 mild subepicardial interstitial fibrosis infiltrating deeper into subepicardial myocardium; 3 5 multifocal subepicardial interstitial fibrosis; and 4 5 replacement fibrosis. Imaging of the sections was performed on a Biorevo BZ-9000 fluorescence microscope (Keyence). Study and identification of the cells present in the coronary lesions were performed using transmission electron microscopy (TEM) or scanning electron microscopy (SEM). Fourteen days after LCWE injection, hearts were removed, dissected into 1-mm specimens, and fixed in 4% glutaraldehyde. Ultrathin sections (70 nm) were cut and examined under TEM or SEM.
Immunofluorescence. Frozen sections of hearts from PBS-and LCWE-injected mice were stained with the following antibodies: anti-mouse CD8 (clone 53-6.7; Tonbo Biosciences), anti-Ly-6G (clone RBC-8C5; eBioscience), anti-CD11b (clone M1/70; eBioscience), anti-F4/80 (clone BM8; eBioscience), anti-mouse CD4 (clone GK1.5; BioLegend), and anti-mouse FoxP3 (clone FJK-16S; eBioscience). Isotype controls were used as negative controls. Before imaging, nuclei were counterstained with ProLong Gold Antifade Reagent containing DAPI (Invitrogen). Images were obtained using a Biorevo BZ-9000 fluorescence microscope.
RNA sequencing. Heart tissue specimens were collected from PBS-injected (n 5 5) and LCWE-injected (n 5 5) WT mice 7 days after injection. RNA was extracted using an RNeasy Mini kit (Qiagen). RNA quality was further determined using a Bioanalyzer (Agilent); only samples with an RNA integrity number .7 were used. RNA sequencing and subsequent analysis were then performed as previously described (14) .
Flow cytometry. The following murine antibodies were used: anti-mouse CD3 (clone 145-2C11; Tonbo Biosciences), anti-mouse CD4 (clone RM4-5; Tonbo Biosciences), anti-mouse CD8, anti-mouse CD25, anti-mouse FoxP3, and anti-mouse CD45.1 (clone A20; eBioscience). Dead cells were routinely excluded based on the staining of eFluor 780 Fixable Viability dye (eBioscience). Stained cells were analyzed on an LSRII flow cytometer (BD Biosciences), and data were processed using FlowJo software (Tree Star).
Reconstitution of RAG-1 -/-mice with CD81 T cells. CD81 T cells were negatively isolated from the spleens of CD45.11 WT C57BL/6 mice, using magnetic beads according to the protocol of the manufacturer (StemCell Technologies). The purity of isolated CD81 T lymphocytes was .94%. On day 0, 4 3 10 6 CD81 T cells suspended in 100 ml of PBS were injected retroorbitally into RAG-1 -/-mice. On day 1, nonreconstituted and reconstituted RAG-1 -/-mice received either PBS or LCWE. KD vasculitis and heart pathology were assessed as described previously.
Statistical analysis. Results are reported as the mean 6 SEM. Statistical analysis was performed with GraphPad Prism software, version 4.03. Mann-Whitney unpaired 2-tailed t-tests were used for comparisons of 2 groups. Fisher's exact tests were used to compare the incidence of coronary lesion formation. For experiments involving .2 groups, we used one-way analysis of variance with Tukey's post hoc analysis. P values less than 0.05 were considered significant.
RESULTS
Proximal and epicardial coronary arteritis and LMP development in the LCWE-induced murine model of KD vasculitis. The LCWE-induced murine model of KD vasculitis has been developed and used to decipher the immunopathologic mechanisms underlying KD development with the ultimate goal of establishing novel and more effective KD therapeutics. The resulting coronary arteritis in the LCWE-induced murine model of KD is characterized by infiltration of inflammatory cells and destruction of the extracellular matrix, especially elastic tissue in vascular media, with resulting formation of coronary artery aneurysms (10) (11) (12) 17) . A recent review questioned whether the LCWE-induced murine model of KD vasculitis may exactly replicate KD pathology in humans as it mostly affects elastic arteries, such as the aorta and the coronary ostium, and not necessarily the primary target of KD in humans, the epicardial muscular coronary arteries (9, 30) .
One week after LCWE injection, WT mice developed coronary artery lesions characterized by the presence of inflammatory cell infiltration and the destruction of elastic tissue in the vascular media, resulting in formation of coronary artery aneurysms ( Figure 1A ). We also observed development of arteritis in the epicardial muscular coronary artery, with absence of damage to the aortic wall ( Figure  1B ). The 3 linked pathologic processes recently reported to lead to KD arteriopathy in humans (acute or necrotizing arteritis, subacute or chronic arteritis, and LMP [8] ) were also replicated in the LCWE-induced murine model of KD vasculitis ( Figure 1C ). The proliferation of medial smooth muscle cells inside the coronary artery lumen may lead to complete coronary artery stenosis ( Figure 1C) .
The inflammation that develops in KD vasculitis in humans is characterized by accumulation of monocyte/ macrophages and plasma cells in coronary artery lesions (21, 31) . TEM and SEM of murine heart sections 14 days after LCWE injection also revealed the presence of monocytes ( Figures 1D and E) , plasma cells ( Figure 1F) , and a fibroblast ( Figure 1G ) in close contact with coronary artery endothelium in mice with KD vasculitis. The identity of these cells was confirmed with specific cell stains in serial sections obtained from the same blocks (results not shown). Therefore, these additional pathologic findings contributed to the overwhelming evidence that the LCWE-induced murine model of KD strongly mimics the main pathologic features of KD in humans, including the presence of epicardial muscular coronary arteritis and development of LMP in the coronary arteries.
Accumulation of CD41 and CD81 T cells in coronary artery lesions of mice with LCWE-induced KD vasculitis. We previously identified the presence of various immune cell types (DCs, plasmacytoid DCs, macrophages, and CD31 T cells) in coronary arteries of KD patients as well as in coronary arteries of LCWEinjected mice (13, 19) . In an effort to better understand the immune cell components of the lesions over time, we 412 NOVAL RIVAS ET AL performed immunofluorescence analyses of heart sections collected from PBS-and LCWE-injected mice 7 and 35 days after injection. As shown in WT mice were treated with either rat IgG isotype or anti-CD25 mAb, and hearts were harvested on day 7 after LCWE injection (see Supplementary Figure 1A (Figures 3E-I) .
We next assessed the potential involvement of NK T cells in LCWE-induced KD vasculitis, as these cells are known to respond to carbohydrate moieties (33) , which make up the LCWE. Since murine KD vasculitis is induced by cell wall extract of L casei, we hypothesized that cell wall-derived carbohydrate moiety recognition by NK T cells might be involved in the development of KD vasculitis. Cd1d
-/-mice were injected with LCWE, and the incidence of KD vasculitis was assessed 2 weeks after injection. Absence of NK T cells did not protect against LCWE-induced vasculitis, since no significant difference was observed in vasculitis Hearts from phosphate buffered saline (PBS)-or LCWE-injected wild-type mice were harvested on days 7 and 35 after injection. A, Hematoxylin and eosin (H&E) staining of frozen heart serial sections. CA 5 coronary artery; Ao 5 lumen of the aorta. B, Immunofluorescence costaining of frozen heart serial sections with isotype control (red), anti-CD8 (red), anti-Ly-6G (red), anti-CD11b (green), anti-F4/80 (green), and DAPI (blue). C, H&E staining and immunofluorescence costaining of frozen heart serial sections with anti-CD4 (green), anti-FoxP3 (red), isotype control (red), and DAPI (blue) 7 days after LCWE injection. Arrowheads indicate CD41FoxP31 Treg cells.
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Requirement for CD81 T cells, but not CD41 T cells, in LCWE-induced vasculitis and myocarditis.
KD vasculitis in humans and murine KD vasculitis are characterized by the accumulation of a large number of DCs and CD31 T cells in the coronary lesions (13, 19) . By acting as antigen-presenting cells, DCs induce and support the adaptive immune response. Although KD Figure 3 . Treg cell depletion does not protect against Lactobacillus casei cell wall extract (LCWE)-induced vasculitis and myocarditis in Kawasaki disease. A, Hematoxylin and eosin (H&E) staining of frozen heart sections from LCWE-injected wild-type (WT) mice treated with anti-CD25 monoclonal antibody or a rat IgG isotype control 7 days after LCWE injection. B-D, Heart vessel inflammation scores (dotted line represents incidence cutoff) (B), vasculitis incidence (C), and myocardial inflammation scores (D) in anti-CD25-or rat IgG-treated LCWE-injected WT mice. E-F, H&E staining of frozen heart sections from phosphate buffered saline (PBS)-or diphtheria toxin (DT)-treated FoxP3 DTR mice 7 days (E) and 14 days (F) after LCWE injection. G-I, Heart vessel inflammation scores (dotted line represents incidence cutoff) (G), vasculitis incidence (H), and myocardial inflammation scores (I) in PBS-or DT-treated FoxP3 DTR mice 7 days and 14 days after LCWE injection. In B and G, symbols represent samples from individual mice; bars show the mean 6 SEM. In D and I, values are the mean 6 SEM. Results are from 5-9 mice per group. lesions in humans are characterized by an influx of CD31 T cells and infiltration in the coronary arterial wall, studies that address the specific functions of CD41 and CD81 T cell subsets in the development of KD vasculitis are lacking (13, 19, 23) . In order to characterize the role of CD41 T cells in the development of KD vasculitis, we injected WT and CD4
-/-mice with LCWE and assessed the incidence, development, and severity of KD vasculitis 1 week after injection (Figures 4A-C) . Absence of CD41 T cells did not prevent the development of LCWE-induced KD vasculitis, as both WT and CD4 -/-mice developed vessel inflammation and myocarditis at the identical frequency and with the same pathologic degree of severity, indicating that CD41 T cells were not required for LCWE-induced KD vasculitis (Figures 4A-C) .
Immunohistochemical staining of coronary artery aneurysm sections obtained from KD patients demonstrated that more CD81 T cells than CD41 T cells were present in the lesion (23) . Interestingly, gene expression analysis showed significant up-regulation of genes associated with CD81 T cell cytotoxic functions, such as CD8a, CD8b1, and granzymes A and B, but not perforin 1, in heart tissues of LCWE-injected mice developing KD vasculitis compared to control naive PBS-injected mice ( Figures 4D and E) . Therefore, we next investigated the function of CD81 T cells in the LCWE-induced murine model of KD vasculitis by using an antibody depletion approach.
WT mice were treated with either anti-mouse CD8a or control rat IgG isotype on days 22, 0, 3, and 5; they were injected with LCWE on day 0 and analyzed for development of KD vasculitis on day 7 (see Supplementary Figure 3A , http://onlinelibrary.wiley.com/doi/10.1002/art. 39939/abstract). Since CD8a is also expressed by a subpopulation of splenic DCs (34) , this depletion treatment could also potentially affect the DC compartment, which is required for the LCWE-induced KD vasculitis model (35) . Therefore, CD81 T cell depletion was also performed using an anti-mouse mAb targeting CD8b, which is only expressed by CD81 T cells (Supplementary Figure 3A) . Both antiCD8a and anti-CD8b depletion treatments were effective, as demonstrated by complete depletion of the splenic CD81 T cell population in treated mice compared to control mice (see Supplementary Figures 3B and C, http://onlinelibrary. wiley.com/doi/10.1002/art.39939/abstract). Compared to LCWE-injected control mice, LCWE-injected CD81 T cell-depleted mice were protected and developed significantly less LCWE-induced vasculitic inflammation as well as significantly decreased myocardial inflammation ( Figures  4F-H) .
Finally, in order to assess the possibility of a functional redundancy between CD41 and CD81 T cells in LCWE-induced development of coronary vasculitis, we performed simultaneous depletion of CD41 and CD81 T cells. CD4 -/-mice were treated with CD8a-depleting mAb and then injected with LCWE to induce KD vasculitis. Acute vasculitis with intense heart vessel and myocardial inflammation developed in CD4 -/-mice treated with the isotype control, while CD81 T cell depletion led to significant protection against development of KD vasculitis in CD4 -/-mice (see Supplementary Figures 4A  and B , http://onlinelibrary.wiley.com/doi/10.1002/art.39939/ abstract). These data indicate that CD41 T cells do not play a role in LCWE-induced vasculitis and myocarditis, while CD81 T cells are a critical factor in determining the severity of the lesions.
Immunofluorescence staining of heart sections from LCWE-injected RAG-1 -/-mice demonstrated the presence of innate inflammatory cells, such as neutrophils (Ly-6G1) and macrophages (F4/801) close to the coronary artery (see Supplementary Figures 5A-C, http://onlinelibrary.wiley.com/doi/10.1002/art.39939/abstract), although at decreased levels compared to those in LCWEinjected WT mice ( Figure 2B ). It has already been reported that T cells, but not B cells, are required for the development of LCWE-induced KD vasculitis, and that LCWEinjected RAG-1 -/-mice have a reduced incidence of heart lesions (13) . Therefore, we reasoned that reconstitution of the CD81 T cell compartment might recapitulate LCWEinduced KD vasculitis in resistant RAG-1 -/-mice. RAG-1 -/-mice were reconstituted with CD45.11CD81 T cells isolated from spleens of WT mice, injected with LCWE, and analyzed 7 days after injection. Adoptively transferred CD81 T cells were retrieved by flow cytometry 7 days after transfer in spleens and draining lymph nodes of recipient mice (see Supplementary Figures 6A and B, http://online library.wiley.com/doi/10.1002/art.39939/abstract). Compared to nonreconstituted LCWE-injected RAG-1 -/-mice, mice reconstituted with CD81 T cells developed KD vasculitis, as evidenced by intense inflammatory cell infiltration around the coronary artery and the aorta ( Figure 5A ). Quantification of heart vessel and myocardial inflammation demonstrated a significantly increased incidence and severity of coronary arteritis and myocardial inflammation in CD81 T cellreconstituted RAG-1 -/-mice ( Figures 5A and B) . These results reveal the importance and the pathogenic role of CD81 T cells in the LCWE-induced murine model of KD vasculitis.
DISCUSSION
In this study, we demonstrated that the LCWEinduced murine model of KD vasculitis replicates additional features of KD pathology in humans, including 416 NOVAL RIVAS ET AL the development of epicardial coronary arteritis and LMP progression, key histologic processes observed in KD pathology in humans. Recently, it has been postulated that 3 distinct, although linked, pathologic processes are involved in the development of KD vasculopathy in humans (8) . The initial process, acute or A, Hematoxylin and eosin (H&E) staining of frozen heart sections from wild-type (WT) and CD4 -/-mice 7 days after LCWE injection. B and C, Heart vessel inflammation (dotted line represents incidence cutoff) (B) and myocardial inflammation (C) scores in LCWE-injected WT and CD4 -/-mice 7 days after injection. D and E, Heatmap (D) and list of expression (E) of genes related to CD81 cytotoxic T cell functions in heart tissues collected from LCWE-injected WT mice (n 5 5) relative to their average expression in heart tissues collected from phosphate buffered saline (PBS)-injected control mice (n 5 5). FDR 5 false discovery rate. F, H&E staining of frozen heart sections from PBS-injected WT mice treated with rat IgG isotype control and from LCWE-injected WT mice treated with anti-CD8a, anti-CD8b, or rat IgG isotype control 7 days after LCWE injection. G and H, Heart vessel inflammation (dotted line represents incidence cutoff) (G) and myocardial inflammation (H) scores in PBS-injected WT mice treated with rat IgG isotype control and in LCWE-injected WT mice treated with anti-CD8a, anti-CD8b, or rat IgG isotype control 7 days after LCWE injection. In B and G, symbols represent samples from individual mice; bars show the mean 6 SEM. In C and H, values are the mean 6 SEM. Results are from 5-12 mice per group. *** 5 P , 0.001 by one-way analysis of variance with Tukey's post hoc test.
necrotizing arteritis, triggers the other 2 processes, subacute or chronic arteritis and LMP in the coronary arteries, potentially ultimately leading to stenosis (8) . The current study demonstrates for the first time that these 3 key histologic features of KD in humans are also recapitulated in LCWE-injected mice developing KD vasculitis. We also report development of epicardial coronary arteritis and the presence of LMP in the coronary arteries of LCWE-injected mice. Using electronic microscopy, we also identified monocytes, histiocytes, and plasma cells in coronary artery lesions of LCWE-injected mice, cell subsets that are also present in coronary arteries in KD patients (8, 21, 31) .
Increasing evidence suggests that KD pathogenesis results from abnormal and imbalanced innate and adaptive immune responses; however, the contributions of the different immunologic cell subsets, such as monocyte/macrophages (31), CD81 T cells (23) , and oligoclonal IgA1 plasma cells (21, 22) , to the development of coronary artery lesions still remain obscure. Strategies aiming to down-modulate the activation of those immune cells and to induce regulatory mechanisms could potentially lead to the development of novel therapeutics.
Several studies demonstrate abnormalities in the Treg cell compartment during KD in humans. Compared to healthy controls or febrile patients with an active non-KD infection, febrile patients in the acute phase of KD exhibit decreased proportions of circulating CD41CD251FoxP31 Treg cells (36, 37) . In vitro, IVIG treatment enhances the suppressive functions of CD41CD251 Treg cells and increases the intracellular expression of FoxP3, IL-10, and transforming growth factor b (27) . The proportion of circulating Treg cells in KD patients thereby returns to the same and normal levels observed in healthy controls between 2 and 3 days after IVIG treatment; however, in IVIG-resistant children, the percentages and absolute numbers of CD41CD251 FoxP31 Treg cells remain significantly lower (25, 36, 38) . We have observed the presence of CD41FoxP31 Treg cells near the coronary artery lesions of LCWE-injected mice; nevertheless, their depletion by 2 different methods did not affect the development of KD vasculitis, coronary arteritis, and myocarditis in this murine model of KD vasculitis. While depletion of Treg cells did not lead to an increase in severity of inflammation, it would be interesting to see whether strategies resulting in expanding Treg cell numbers, such as Treg cell adoptive transfer, could lead to decreased disease development and incidence.
KD vasculitis in humans is characterized by intense CD31 T cell infiltration in the arterial layers of coronary aneurysms in KD patients (19, 39) . Among the inflammatory infiltrates, CD31CD81 T cells are more prevalent than CD41 T cells in KD patients as compared to healthy controls (23, 24, 39) . Furthermore, RNA sequencing of coronary artery tissues obtained from KD patients and non-KD control patients demonstrated significant up-regulation of pathways associated with activated cytotoxic T lymphocyte function, antigen presentation, Toll-like receptor (TLR) signaling, and type I interferon (IFN) response in patients with KD arteritis compared to non-KD control patients (40) .
Histopathologic studies of the LCWE-induced murine model of KD vasculitis revealed lesions similar to those in humans with KD, with the presence of both T cells and DCs in the coronary arteries (13) . While B cell-deficient mice retained normal LCWE-induced KD vasculitis lesions, RAG-1 -/-mice were protected, indicating an important role for T cells in this model of KD (13) . In this study, we have shown that both CD41 and CD81 T cells were present in LCWE-induced coronary lesions and that CD81 T cells play a critical role in LCWE-induced KD vasculitis. Our RNA sequencing data also demonstrate increased expression of genes associated with CD81 T cell cytotoxic functions, such as granzymes A and B, in heart tissues of LCWE-injected mice compared to PBS-injected mice. Guzman-Cottrill et al also reported the predominant presence of CD81 T cells in inflammatory cell infiltrates during acute coronary arteritis in humans with KD; surprisingly, however, those CD81 T cells did not express the cytotoxic proteins granzyme B and perforin (39) . Cytotoxic CD81 T cells also produce IFNg; however, this cytokine does not appear to have a key function in LCWE-induced KD vasculitis, since LCWE-injected IFNg -/-mice demonstrate disease incidence and coronary arteritis similar to those in WT mice (15, 41) .
We have previously shown that caspase 1/IL-1a and IL-1b pathways are important for the development of coronary arteritis, myocarditis, and abdominal aorta aneurysm in the LCWE-induced murine model of KD vasculitis (14, 15, 35) . The body of evidence supporting the importance of the IL-1 pathway in KD pathogenesis is now compelling enough for the launch of 3 different clinical trials of IL-1 blockade for treatment of acute KD (18) . Interestingly, IL-1 was shown to expand and enhance the differentiation of antigen-specific CD81 T cells in vitro and in vivo (42, 43) . IL-1 also increases antigen-driven proliferation of CD41 T cells; however, the effect of IL-1 on CD81 T cells has been reported to be independent of the presence of CD41 T cells (43, 44) .
In the present study, we show that the absence of CD41 T cells does not impact the development and incidence of LCWE-induced KD vasculitis. On the other hand, CD81 T cells had a dramatic effect on the development of LCWE-induced KD vasculitis; their depletion significantly decreased coronary arteritis and myocarditis, while their adoptive transfer significantly enhanced vasculitis development in RAG-1 -/-mice, a strain known to be resistant to LCWE-induced vasculitis. Still, the mechanisms by which IL-1 promotes CD81 T cell expansion remain unknown, appear to be direct, and require the expression of IL-1RI by CD81 T cells (43) . It has been suggested that IL-1 could block activation-induced CD81 T cell death by decreasing their FasL expression (45) . Because KD pathogenesis is thought to have an autoimmune component, perhaps CD81 T cells may act differently from usual cytotoxic cells and promote coronary arteritis by inducing apoptosis in otherwise normal healthy cells associated with the coronary arteries. CD81 T cells have also been found to secrete various chemokines, which could lead to recruitment of immune cells to the lesions. Further studies are needed to characterize the precise mechanisms by which CD81 T cells affect and participate in the pathology of LCWE-induced KD vasculitis.
A possible sequential model of KD pathology development is that LCWE activates macrophages and DCs through the TLR-2/myeloid differentiation factor 88 pathway (12) and induces their production of inflammatory cytokines, including IL-1b and IL-1a (15) . The IL-1 released in the environment further acts on stromal cells near the sites of lesion development to promote additional release of proinflammatory cytokines and chemokines and to boost the influx of inflammatory cells (35) . At the same time, DCs that colocalized in coronary artery lesions near the CD31 T cells present the antigen and stimulate an autoimmune response mediated by the activated CD81 T cells. The T cells migrate to the sites of inflammation along with neutrophils, DCs, and macrophages to fully institute development of vasculitic lesions.
While the etiology of KD remains elusive, new treatment modalities are still needed, especially for children who do not respond to IVIG treatment and are at increased risk of coronary artery abnormalities. While the LCWE-induced murine model of KD vasculitis only serves as a proxy for KD in humans, it has allowed us to model new therapeutics, predicted the use of IVIG and anti-tumor necrosis factor in the clinical setting, and generated 2 clinical trials investigating the use of anakinra in KD patients (NCT02390596 and NCT02179853) (18, 46) and 1 clinical trial using anti-IL-1b (European Clinical Trials 2015-003763-11) (46) . Our current studies identified CD81 T cells as playing an important role in lesion development, and this finding makes them a potential target of therapy. Until we know the exact etiology and immunopathology of KD in humans, continued research using the mouse model of KD vasculitis remains an important endeavor.
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